PharmaBoardroom

Interview: Mohamed El-Sahhar – Country Head, Boehringer…

Egypt is at the ‘golden stage’ for investment, claims Boehringer Ingelheim country head Mohamed El-Sahhar, who explains how the company is…

Interview: Jasper van Grunsven – General Manager, Amgen…

Amgen Netherlands is preparing to launch five new products next year, including their leading cardiovascular biotech product Repatha and recently…

Interview: Philippe Luscan – President & Executive…

Philippe Luscan reveals how Sanofi contributes almost USD 6.35 billion net to the French economy; how their five new global business units will drive…

Interview: Christian Deleuze – President, Sanofi Genzyme…

Christian Deleuze reveals the impact of the acquisition by Sanofi in 2011; explains the profitability and global reach of the bio manufacturing…

Interview: Michel Spagnol – Chairman & CEO, Novasep,…

Novasep is the largest contract manufacturer for the pharmaceuticals and fine chemicals industries in France. Michel Spagnol, the company’s chairman…

Interview: Bruno Masurel – Head of International Division,…

Lyon provides companies with a flamboyant and collaborative environment to develop. Bruno Masurel, Head of the International Division of the local…

Interview: Dr. Giorgio Pisani – President & CEO, IBSA…

Dr. Giorgio Pisani, President and CEO of IBSA Italy, talks about his founding of the company in 2001 and its rapid growth in the market through a…

Interview: Prof. Walter Ricciardi – President, Italian…

Prof. Walter Ricciardi has just been appointed as the new president for the Italian National Institute of Health (ISS). He explains his priorities…

Interview: Maikel Beerens – Founder and CEO, Xilloc, The…

Maikel Beerens, CEO and founder of Xilloc, a promising Dutch company that designs patient-specific implants, anatomical models and surgical guides for…